Sumit chrono
7 months ago
Stem Cell Therapy for Macular Dystrophy in Iran: embryonic, induced and mesenchymal cells explained
Not all stem cells are the same. This page explains the main cell types, how they might reach the macula and why those differences matter when you read a claim.
Different cells, different goals
Embryonic and induced pluripotent stem cells can be turned into retinal cell types in the laboratory. Mesenchymal cells, taken from bone marrow, fat or cord tissue, are not expected to become retina and are studied mainly for the support signals they release.
A claim that stem cells helped therefore means little until you know which cells were used and how they were delivered.
Questions to ask about any cell product
These separate research from marketing.
- Which cell type?Pluripotent-derived, mesenchymal or another.
- Where did it come from?Your own body or a donor.
- How was it made?Laboratory standards and quality checks.
- How is it delivered?Under the retina, into the vitreous or around the eye.
- What was measured?Imaging, field or reading outcomes.
Delivery routes and trade-offs
No route has proven benefit for macular dystrophy.
Subretinal placement
Closest to the macula but needs delicate retinal surgery.
Intravitreal injection
Simpler, but cells may not reach the target layers.
Suprachoroidal delivery
A newer route studied for lower surgical risk.
Evidence so far
Mostly early-phase safety studies.
Staying safe while you research
Protect your remaining sight.
Avoid guaranteed-result offers
Be wary of promises of recovery.
Share plans with your retina specialist
They know your baseline.
Keep imaging current
Scans before any procedure are essential.
Ask for risks in writing
Before agreeing to anything.
Our Medical Experts – Trusted Specialists
Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.
Dr. Pallavi
Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years ExperienceDr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.
Get ConsultationDr. Robin
Consultant Ophthalmologist & Eye Surgeon | MD, DO 16+ Years ExperienceDr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.
Get ConsultationDr. Pawan
Associate Professor | Vitreo-Retina Surgeon 10+ Years ExperienceDr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.
Get ConsultationFrequently asked questions
Can mesenchymal cells replace macular cells?
Current evidence suggests they act through support signals rather than becoming retinal cells.
What are induced pluripotent stem cells?
Adult cells reprogrammed into a stem-like state, then guided to become retinal cells.
Is one delivery route safest?
Each has trade-offs and none is proven for macular dystrophy.
